Heart Disease Clinical Trials in Detroit

Showing 101-120 of 460 trials

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

NCT06062329

Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism

Acute Pulmonary EmbolismThromboembolismEmboli, Pulmonary+5 more

Imperative Care, Inc.109 participantsStarted Dec 2023

Huntsville, Alabama, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +16 more locations

COMPLETED< 1 mile

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

NCT06212466

A prospective, multicenter, observational, single-arm trial to validate CardioFlux MCG's ability to diagnose myocardial ischemia caused by coronary microvascular dysfunction in patients with suspected ischemia and confirmed no obstructive coronary artery disease (suspected INOCA) by using diagnostic measures of coronary flow reserve (CFR) via invasive angiography as a reference standard for diagnosis.

Ischemic Heart DiseaseCoronary Microvascular DiseaseAngina+1 more

Genetesis Inc.136 participantsStarted Jun 2024

Gainesville, Florida, United States • Edgewood, Kentucky, United States • Detroit, Michigan, United States +5 more locations

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

Heart Disease Trials in Other Cities

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Validation of CardioMEMS HF System Cardiac Output Algorithm IDE

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Cardiovascular Health Improvement Project

Cardiac Rehabilitation to Improve Breast Cancer Outcomes

Hybrid Coronary Revascularization Trial

Long Term Follow Up for CTSN Mitral Valve Repair Studies

SURPASS Impella 5.5 Study

Imaging Study of Allocation of Pacing Targets in Cardiac Resynchronization Therapy

Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend

Global Utilization And Registry Database for Improved heArt preservatioN

Abbott Vascular Medical Device Registry

AB-1002 in Patients With Class III Heart Failure

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Conduction System Pacing Optimized Therapy

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Other Conditions in Detroit